title: A comparative study of antipsychotic medication taking in people with schizophrenia.
abstract: Medication adherence is problematic in all chronic illnesses, none more so than in individuals with schizophrenia. The purpose of this exploratory study was to examine the factors that impacted upon antipsychotic medication taking in people with schizophrenia living in regional-rural and metropolitan Victoria, Australia, and to assess if differences existed between these two groups of participants in the factors that affected medication taking. The Factors Influencing Neuroleptic Medication Taking Scale was used with a non-probability survey sample of 81 people with schizophrenia. Ethics approval was given by university and hospital ethics committees. The results showed, overall, that there were no significant differences between the sets of participants in several demographic characteristics, insight, stigma, substance abuse, types of antipsychotic medications, significant others' support, and access to case managers and general practitioners. There were statistically significant differences between the two groups concerning living circumstances, involvement in religious/spiritual activities, perceived impact of medication side-effects, and access to psychiatrists. However, there were no statistically significant relationships between these factors and medication omission. The implications of the findings for consumers, mental health nurse case managers, families, mental health service provision, and further research, are considered.
authors.affiliation: School of Nursing and Midwifery, Victoria University, Melbourne, Victoria, Australia. terence.mccann@vu.edu.au
authors.forename: Terence V
authors.initials: TV
authors.lastname: McCann
authors.forename: Cecil
authors.initials: C
authors.lastname: Deans
authors.forename: Eileen
authors.initials: E
authors.lastname: Clark
authors.forename: Sai
authors.initials: S
authors.lastname: Lu
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002908:Chronic Disease; D005260:Female; D006297:Health Services Accessibility; D006306:Health Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000523:psychology*; D012559:Schizophrenia / Q000188:drug therapy / Q000451:nursing*; D012565:Schizophrenic Psychology; D055502:Secondary Prevention; D012931:Social Environment; D012944:Social Support; D029181:Spirituality; D014739:Victoria
chemical_list: D014150:Antipsychotic Agents